Nano Flow’s Influenza A (Flu A) gold conjugate is based on a monoclonal antibody targeting the Influenza A nucleoprotein, a highly conserved antigen across Influenza A strains. Validated as a detection antibody in lateral flow assays, this conjugate ensures sensitive and specific detection of Influenza A infections. The corresponding capture antibody is also available, providing a complete pair solution for assay developers.
Influenza A (Flu A) Gold Conjugate – 40 nm (Ref NF-FLUA-AU)
This antibody shows no cross-reactivity with Influenza B, adenovirus, RSV, parainfluenza, Mycoplasma pneumoniae, or SARS-CoV-2, ensuring high diagnostic specificity. Produced on Nano Flow’s highly spherical 40 nm gold nanoparticles (OD20), it delivers reproducibility, stability, and strong visual signals across assay platforms.
Applications: Lateral flow assays (LF) and other immunoassay formats.
Certificate of Analysis: Supplied with each batch, including TEM, DLS, and UV-Vis characterization.
Technical Specifications
| Parameter | Specification |
|---|---|
| Antibody format | IgG1 |
| Host | CHO cells |
| Clonality | Monoclonal |
| Specificity | Influenza A nucleoprotein |
| Cross-reactivity | None with Influenza B, adenovirus, RSV, parainfluenza, M. pneumoniae, or SARS-CoV-2 |
| Gold nanoparticle size | 40 nm |
| Concentration of the gold conjugate | OD20 |
| Buffer | Borate, BSA 0.25%, NaN₃ 0.09%, pH 7.3 |
| Shelf life | 1 year |
| Available volumes | From 1 ml to 1 L+ |
